Donate

Antiandrogens

The World

Abiraterone shows promise in prostate cancer fight, Dimebon for Alzheimer’s

August 14, 2013Environment

A 21-patient study has shown that the drug abiraterone can stop the testosterone that feeds prostate cancer. A larger international clinical trial is underway to test the drug before it can be deemed a ‘miracle drug. Also, Dimebon, once used as an antihistamine, has been found to improve cognitive abilities for Alzheimer’s patients.

Latest Headlines

Amid Madrid mega-statue hype, a small bronze dog shines
Serbians caught between East and West struggle to keep warm
At a time of crisis for Haiti, a filmmaker reflects on past US intervention
France moving to the right as voters head to the polls for local elections
After Israeli strikes on Tehran’s fuel depots, residents face a toxic aftermath
Turkey’s Izmir facing severe shortages as water levels continue to drop
AI is rapidly changing math, and mathematicians are defining their role in the equation
Minnesota’s Hmong community feeling a sense of betrayal amid ICE crackdowns
Surströmming challenge: How Swedes actually eat the world’s worst-smelling food
A brief history of US, Israeli and Iranian relations
More stories

The World is a public radio program that crosses borders and time zones to bring home the stories that matter.

Produced by

Thanks to our sponsor

  1. Progressive Insurance logo

Major funding provided by

  1. Carnegie Corporation of New York

  1. About
  2. Contact
  3. Donate
  4. Meet the Team
  5. Privacy
  6. Terms of use

©2026 The World from PRX

PRX is a 501(c)(3) organization recognized by the IRS: #263347402.